Literature DB >> 1317993

Tissue breakdown and exposure associated with orbital hydroxyapatite implants.

H Buettner1, G B Bartley.   

Abstract

Tissue breakdown and exposure of a hydroxyapatite implant were observed in eight patients: in four of six patients after evisceration and in four of 31 after enucleation. The reasons for evisceration were a blind, painful eye and endophthalmitis in two patients each. The reasons for enucleation were a choroidal melanoma in two patients and endophthalmitis and irreparable traumatic damage in one patient each. The patients with endophthalmitis received the implant in a second surgical procedure after intensive antibiotic treatment. Small tissue defects healed spontaneously, whereas large defects showed little tendency to heal by secondary intention. Tissue breakdown over a hydroxyapatite implant may be related to delayed ingrowth of fibrovascular tissue, and possibly related to an inflammatory reaction incited by the hydroxyapatite. Careful case selection, facilitation of tissue penetration by drilling holes into the hydroxyapatite sphere, delayed fitting of the prosthesis, and vaulting of the posterior surface of the initial prosthesis to reduce pressure on the tissues covering the anterior pole of the implant may alleviate the problems of tissue breakdown and exposure.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1317993     DOI: 10.1016/s0002-9394(14)74792-0

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  17 in total

1.  Autogenous temporalis fascia patch graft for porous polyethylene (Medpor) sphere orbital implant exposure.

Authors:  M S Sagoo; J M Olver
Journal:  Br J Ophthalmol       Date:  2004-07       Impact factor: 4.638

2.  Surgical coverage of exposed hydroxyapatite implant with retroauricular myoperiosteal graft.

Authors:  S L Liao; S C S Kao; J H S Tseng; L L-K Lin
Journal:  Br J Ophthalmol       Date:  2005-01       Impact factor: 4.638

3.  Amniotic membrane transplantation for porous sphere orbital implant exposure.

Authors:  Yan-hong Chen; Hong-guang Cui
Journal:  J Zhejiang Univ Sci B       Date:  2007-09       Impact factor: 3.066

4.  Remove, rotate, and reimplant: a novel technique for the management of exposed porous anophthalmic implants in eviscerated patients.

Authors:  P Kaynak; G O Karabulut; C Ozturker; I Perente; B Gökyiǧit; A Demirok; O F Yilmaz
Journal:  Eye (Lond)       Date:  2014-02-07       Impact factor: 3.775

Review 5.  Integrated versus non-integrated orbital implants for treating anophthalmic sockets.

Authors:  Silvana Schellini; Regina El Dib; Leandro Re Silva; Joyce G Farat; Yuqing Zhang; Eliane C Jorge
Journal:  Cochrane Database Syst Rev       Date:  2016-11-07

6.  Lack of complications of the hydroxyapatite orbital implant in 250 consecutive cases.

Authors:  C L Shields; J A Shields; P De Potter; A D Singh
Journal:  Trans Am Ophthalmol Soc       Date:  1993

7.  Problems with the hydroxyapatite orbital implant: experience with 250 consecutive cases.

Authors:  C L Shields; J A Shields; P De Potter; A D Singh
Journal:  Br J Ophthalmol       Date:  1994-09       Impact factor: 4.638

8.  Long term follow up of bone derived hydroxyapatite orbital implants.

Authors:  A J Suter; A C B Molteno; T H Bevin; J D Fulton; P Herbison
Journal:  Br J Ophthalmol       Date:  2002-11       Impact factor: 4.638

9.  Effects of vascular endothelial cell growth factor on fibrovascular ingrowth into rabbits hydroxyapatite orbital implant.

Authors:  Hong Zhang; Guigang Li; Caini Ji; Hua He; Junming Wang; Weikun Hu; Hua Wu; Jing Chen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2004

10.  Effect of basic fibroblast growth factor (bFGF) on the treatment of exposure of the orbital implants.

Authors:  Hong-guang Cui; Hui-yan Li
Journal:  J Zhejiang Univ Sci B       Date:  2007-09       Impact factor: 3.066

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.